GCT interview for US Biopharma 2019

GCT Director of Business Development, Nataliya Katsnelson spoke with the Global Business Reports editors about the benefits of conducting clinical research abroad and the recent changes in the industry. While the volume of research in the United States  dominates other regions due to it’s market attractiveness for the  companies worldwide, the obvious growth of international research is evident.

The interview was published in the GBR issue of United States Biopharmaceuticals 2019, which comprises the following related topics: R&D, Contract Services, Drug discovery, Regulations and compliance, and more.

The publication can be accessed via this link: https://www.gbreports.com/files/pdf/_2019/US_Biopharma_2019.pdf

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.